The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review

The discovery of immune checkpoint inhibitors (ICIs) has revolutionized the care of cancer patients. However, the response to ICI therapy exhibits substantial interindividual variability. Efforts have been directed to identify biomarkers that predict the clinical response to ICIs. In recent years, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Araji, Ghada, Maamari, Julian, Ahmad, Fatima Ali, Zareef, Rana, Chaftari, Patrick, Yeung, Sai-Ching Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138420/
https://www.ncbi.nlm.nih.gov/pubmed/35663831
http://dx.doi.org/10.36401/JIPO-21-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138420/
https://www.ncbi.nlm.nih.gov/pubmed/35663831
http://dx.doi.org/10.36401/JIPO-21-10

Ejemplares similares